Hawthorne, NJ, United States of America

John Guilfoyle Mullin, Jr


Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2001-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Profile: John Guilfoyle Mullin, Jr.

Introduction

John Guilfoyle Mullin, Jr. is an accomplished inventor based in Hawthorne, NJ, USA. With a strong focus on pharmaceutical innovations, he holds five patents that contribute significantly to the field of cancer treatment. His work is characterized by the development of novel compounds that have potential therapeutic applications.

Latest Patents

Mullin's latest work revolves around the synthesis of 4-aminopyrimidine-5-one derivatives. These novel intermediate compounds are particularly valuable for their ability to inhibit cyclin-dependent kinases, specifically cyclin-dependent kinase 4 (Cdk4). The 4-aminopyrimidine-5-one derivatives and their pharmaceutically acceptable salts exhibit antiproliferative activity, making them useful in treating various forms of cancer, including solid tumors. Furthermore, these compounds have potential applications in the treatment of breast, lung, colon, and prostate cancers, highlighting their versatility in oncology.

Career Highlights

Throughout his career, Mullin has made significant contributions to pharmaceutical research and development. His expertise in synthesizing novel chemical compounds has not only enriched his patent portfolio but has also advanced the understanding of treatments for aggressive cancers. His patents emphasize his commitment to addressing one of the most pressing health challenges of our time.

Collaborations

John Guilfoyle Mullin, Jr. collaborates with talented colleagues such as Allen John Lovey and Qingjie Ding. Their teamwork fosters an innovative environment that drives the discovery of effective pharmaceutical solutions, highlighting the importance of collaboration in the field of research and development.

Conclusion

In summary, John Guilfoyle Mullin, Jr. stands as a key figure in pharmaceutical innovation, particularly within cancer treatment research. His patented inventions underscore the significant impact that novel compounds can have on patient outcomes, making him a notable inventor in the realm of healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…